Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR | P06401 | 1/20 | 0.64 |
| ▸ | RORA | P35398 | 1/20 | 0.64 |
| ▸ | RORC | P51449 | 1/20 | 0.64 |
| ▸ | RORB | Q92753 | 1/20 | 0.64 |
| ▸ | MAOA | P21397 | 11/20 | 0.60 |
| ▸ | MAOB | P27338 | 11/20 | 0.60 |
| ▸ | GRIN1 | Q05586 | 9/20 | 0.60 |
| ▸ | GRIN2A | Q12879 | 9/20 | 0.60 |
| ▸ | GRIN2B | Q13224 | 9/20 | 0.60 |
| ▸ | ACHE | P22303 | 3/20 | 0.60 |
| ▸ | CNR2 | P34972 | 1/20 | 0.60 |
| ▸ | PSEN1 | P49768 | 3/20 | 0.59 |
| ▸ | PSEN2 | P49810 | 3/20 | 0.59 |
| ▸ | APH1B | Q8WW43 | 3/20 | 0.59 |
| ▸ | NCSTN | Q92542 | 3/20 | 0.59 |
| ▸ | APH1A | Q96BI3 | 3/20 | 0.59 |
| ▸ | PSENEN | Q9NZ42 | 3/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5153894 | 1.00 | PGR (0.64) | PGRRORARORCRORBMAOA | |
| SCHEMBL6575875 | 1.00 | PGR (0.64) | PGRRORARORCRORBMAOA | |
| SCHEMBL29490761 | 1.00 | PGR (0.64) | PGRRORARORCRORBMAOA | |
| SCHEMBL6275417 | 1.00 | PGR (0.64) | PGRRORARORCRORBMAOA | |
| SCHEMBL6774209 | 1.00 | PGR (0.64) | PGRRORARORCRORBMAOA | |
| SCHEMBL6278388 | 1.00 | PGR (0.64) | PGRRORARORCRORBMAOA | |
| SCHEMBL1000878 | 1.00 | PGR (0.64) | PGRRORARORCRORBMAOA | |
| SCHEMBL1001993 | 1.00 | PGR (0.64) | PGRRORARORCRORBMAOA | |
| SCHEMBL750975 | 1.00 | PGR (0.64) | PGRRORARORCRORBMAOA | |
| SCHEMBL29557199 | 1.00 | PGR (0.64) | PGRRORARORCRORBMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12041851-B2 | Compound and organic light emitting device comprising same | LG CHEM, LTD. (KR) | 2024-07-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12041851-B2 | Compound and organic light emitting device comprising same | CRY1, CYP1A1, TRPA1 | PGR 2378/4885RORA 432/4885RORC 598/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.